MiR-106a-5p Promotes 5-FU Resistance and the Metastasis of Colorectal Cancer by Targeting TGFβR2

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 18

PMID 31949649

Citations 17

Authors

Jian Liu

Yanqin Huang

Hongqian Wang

Denghai Wu

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths. 5-Fluorouracil (5-FU)-based chemotherapy has always been the first-line treatment. However, development of 5-FU resistance seriously affects its curative effect. The aim of this study was to elucidate the molecular mechanisms of 5-FU resistance through miR-106a-5p in CRC.

Methods: Colorectal cancer tissues were collected to analyze miR-106a-5p and TGFβR2 expressions by qPCR. Functional experiments for evaluating cell survival and metastasis were conducted to observe the biological effects of miR-106a-5p and TGFβR2. The cell survival rate was calculated using an MTT assay; the metastasis was confirmed with a Transwell invasion assay and Western blotting, which we used to measure the expression levels of the epithelial-mesenchymal transition (EMT) markers E-cadherin and vimentin. The combination of miR-106a to TGFβR2 was predicted using , and confirmed through the construction of the luciferase reporter plasmid pGL3-basic. The interplay between miR-106a-5p and TGFβR2 was tested with qPCR and Western blotting. A Spearman rank analysis was employed to verify the correlation of miR-106a-5p and TGFβR2 expressions.

Results: MiR-106a-5p was up-regulated and TGFβR2 was down-regulated in 5-FU resistant CRC tissues and HT-29 cells. MiR-106a-5p promoted cell survival and suppressed the apoptosis rate and caspase 3 activity. Additionally, cell invasion was promoted by miR-106a-5p overexpression in the HT-29 cells and was inhibited by miR-106a-5p knockdown in the 5-FU resistant HT-29 cells; miR-106a-5p overexpression contributed to migration by increasing vimentin expression and by decreasing E-cadherin expression in the HT-29 cells; miR-106a-5p functioned by directly binding to TGFβR2. The TGFβR2 knockdown conferred chemoresistance of 5-FU and metastasis in 5-FU resistant HT-29 cells, and TGFβR2 overexpression reduced cell survival, invasion numbers, vimentin expression, and increased the cell apoptosis rate and caspase 3 activity in 5-FU resistant HT-29 cells. Also, miR-106a-5p negatively regulated TGFβR2 in a linear correlation way in the CRC tissues.

Conclusion: The up-regulation of miR-106a-5p contributes to the pathomechanism of colorectal cancer by promoting 5-FU resistance and metastasis via inhibiting target TGFβR2. Our findings provide new promising ways for the clinical application of the TGFβR2-miR-106a axis in clinical chemotherapy for 5-FU resistant colorectal cancer.

Citing Articles

KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cells.

Zhang B, Qi T, Lin J, Zhai S, Wang X, Zhou L Exp Mol Med. 2025; .

PMID: 40082673 DOI: 10.1038/s12276-025-01424-1.

Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.

Zabeti Touchaei A, Norollahi S, Najafizadeh A, Babaei K, Bakhshalipour E, Vahidi S Cancer Cell Int. 2024; 24(1):334.

PMID: 39369258 PMC: 11453077. DOI: 10.1186/s12935-024-03514-y.

Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma.

Gu X, Li X, Zhang X, Tong L, Feng R, Liu L Onco Targets Ther. 2023; 16:767-783.

PMID: 37771939 PMC: 10522466. DOI: 10.2147/OTT.S416155.

The Critical Function of microRNAs in Developing Resistance against 5- Fluorouracil in Cancer Cells.

Sheikhnia F, Maghsoudi H, Majidinia M Mini Rev Med Chem. 2023; 24(6):601-617.

PMID: 37642002 DOI: 10.2174/1389557523666230825144150.

Overview of miR-106a Regulatory Roles: from Cancer to Aging.

Daneshpour M, Ghadimi-Daresajini A Bioengineering (Basel). 2023; 10(8).

PMID: 37627777 PMC: 10451182. DOI: 10.3390/bioengineering10080892.

References

Xiong W, Ai Y, Li Y, Ye Q, Chen Z, Qin J . Microarray Analysis of Circular RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells. Biomed Res Int. 2017; 2017:8421614. PMC: 5471554. DOI: 10.1155/2017/8421614. View

Li J, Li X, Cen C, Ai X, Lin C, Hu G . The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31. Oncol Rep. 2017; 39(1):217-226. DOI: 10.3892/or.2017.6082. View

Gruszka R, Zakrzewska M . The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors. Int J Mol Sci. 2018; 19(3). PMC: 5877740. DOI: 10.3390/ijms19030879. View

Komatsu S, Ichikawa D, Tsujiura M, Konishi H, Takeshita H, Nagata H . Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res. 2012; 33(1):271-6. View

Guzman E, Johnson J, Linley P, Gunasekera S, Wright A . A novel activity from an old compound: Manzamine A reduces the metastatic potential of AsPC-1 pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosis. Invest New Drugs. 2010; 29(5):777-85. PMC: 3085053. DOI: 10.1007/s10637-010-9422-6. View

Tan W, Li Y, Lim S, Tan T . miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol. 2014; 20(20):5962-72. PMC: 4033436. DOI: 10.3748/wjg.v20.i20.5962. View

Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H . Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Breast Cancer Res Treat. 2018; 170(2):257-270. PMC: 5999170. DOI: 10.1007/s10549-018-4757-3. View

Qu Y, Zhang H, Duan J, Liu R, Deng T, Bai M . MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer. Oncotarget. 2016; 7(22):33286-96. PMC: 5078094. DOI: 10.18632/oncotarget.8946. View

Tong M, Zheng W, Li H, Li X, Ao L, Shen Y . Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy. Oncogenesis. 2016; 5(7):e242. PMC: 5399173. DOI: 10.1038/oncsis.2016.51. View

10.

Paydas S, Acikalin A, Ergin M, Celik H, Yavuz B, Tanriverdi K . Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables. Med Oncol. 2016; 33(4):34. DOI: 10.1007/s12032-016-0749-5. View

11.

Hoey C, Ray J, Jeon J, Huang X, Taeb S, Ylanko J . miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation. Mol Oncol. 2018; 12(8):1324-1341. PMC: 6068351. DOI: 10.1002/1878-0261.12328. View

12.

Shen L, Qu X, Ma Y, Zheng J, Chu D, Liu B . Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer. Oncogenesis. 2014; 3:e86. PMC: 3940918. DOI: 10.1038/oncsis.2013.48. View

13.

Thierauf J, Veit J, Hess J . Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer. Cancers (Basel). 2017; 9(7). PMC: 5532612. DOI: 10.3390/cancers9070076. View

14.

Qin Y, Huo Z, Song X, Chen X, Tian X, Wang X . mir-106a regulates cell proliferation and apoptosis of colon cancer cells through targeting the PTEN/PI3K/AKT signaling pathway. Oncol Lett. 2018; 15(3):3197-3201. PMC: 5778839. DOI: 10.3892/ol.2017.7715. View

15.

Cai N, Hu L, Xie Y, Gao J, Zhai W, Wang L . MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-β receptor 2. Eur Rev Med Pharmacol Sci. 2018; 22(7):1899-1906. DOI: 10.26355/eurrev_201804_14712. View

16.

Ullmann P, Rodriguez F, Schmitz M, Meurer S, Qureshi-Baig K, Felten P . The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis. Cancer Res. 2018; 78(14):3793-3808. DOI: 10.1158/0008-5472.CAN-17-3003. View

17.

Ahmed N, Abubaker K, Findlay J, Quinn M . Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets. 2010; 10(3):268-78. DOI: 10.2174/156800910791190175. View

18.

Hu B, Cai H, Zheng R, Yang S, Zhou Z, Tu J . Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Int J Biochem Cell Biol. 2017; 92:34-42. DOI: 10.1016/j.biocel.2017.09.008. View

19.

Chu T, Yang C, Liu C, Lui M, Lin S, Chang K . miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. Cancer Lett. 2013; 337(1):115-24. DOI: 10.1016/j.canlet.2013.05.032. View

20.

Yang X, Cheng T, He Q, Lei Z, Chi J, Tang Z . LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Mol Cancer. 2018; 17(1):126. PMC: 6106894. DOI: 10.1186/s12943-018-0874-1. View